Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)
Sponsor: Impatients N.V. trading as myTomorrows
This observational or N/A phase trial investigates Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant and Acute-graft-versus-host Disease and is currently ongoing. Impatients N.V. trading as myTomorrows leads this study, which shows 9 recorded versions since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
No Longer Available
-
Jul 2024 — Sep 2024 [monthly]
No Longer Available
-
Jan 2021 — Jul 2024 [monthly]
No Longer Available
-
Oct 2020 — Jan 2021 [monthly]
No Longer Available
Status: Available → No Longer Available
-
Mar 2020 — Oct 2020 [monthly]
Available
▶ Show 4 earlier versions
-
Dec 2018 — Mar 2020 [monthly]
Available
-
Sep 2018 — Dec 2018 [monthly]
Available
-
Apr 2018 — Sep 2018 [monthly]
Available
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Available NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Impatients N.V. trading as myTomorrows
- Kamada, Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.